Operating revenue KSEK ## (##)Income after financial items KSEK -## ## (-## ##)Earnings per share -##,## (-##,##)Cash and cash equivalents as of ## December KSEK ## ## (## ##)Equity ratio as of ## December ##,## (##,##) %Financial year (## January to ## December 2017)
Throughout the year, the company worked to raise capital to conduct a clinical Phase ##b trial with ## weeks' treatment to reproduce the substantial results that were achieved after ## weeks' treatment in an earlier OxyPharma study.
Summary
Table of Contents
Search Inside
Cyxone AB is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases.The company's lead product contain T20K, a compound to inhibit pro-inflammatory cytokines, including IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral administration.
It also offers cyclotides, a additional class of highly particular low toxicity drugs that can be used for different immune-related diseases and cancers.Cyxone collaborates with other medical universities for the development of cyclotide.
The company also conducts preclinical studies and phase I clinical trials.It operates across Austria (AT) and Germany (DE).
Cyxone is based in Malmo, Sweden (SE).
Cyxone AB - Pharmaceuticals & Healthcare - Transactions and Alliances Profile offers you detailled data and trend analysis of the company's Mergers and Acquisitions, alliances and financings.The study offers exhaustive data on Private Equity, Mergers and Acquisitions, Venture Financing, Equity/Debt Offerings, Venture Financing and Partnership transactions reported by the firm over a 5-year period.
The study provides extensive comparative data on: number of transactions, their values -subdivided into transactions types-, sub-sectors and areas.
GlobalData used data coming from Pharma eTrack deals database, primary and secondary research.
- Financial transactions - Analysis of the company's financial transactions including mergers and Acquisitions, Equity/Corporate debt offerings, Private equity investment, Venture capital financing and Alliances.
- Transactions by Year - Chart and table displaying information including the number of transactions and value described by the company by year, for a five year period.
- Transactions by Category - Chart and table depicting info containing the number of business deals and value announced by the company by type including Mergers and Acquisitions, Equity/Corporate debt offering etc.
- Transactions by Region - Chart and table presenting data on the number of accords and value described by the company by region, which comprises North America continent, Europe (EU), Asia Pacific (APAC), the Middle East (ME) and African continent and South and Central America.
- Transactions by Sub-sector - Chart and table showing data on the number of transactions and value announced by the company, by sub-sector.
- Main deals - Data on the company's main financial deals. Each such deal has a short statement, business deal type, deal justification; and deal financials and target company's main financial metrics and ratios.
- Business overview - A succinct description of the company's opertations.
- Main employees - A list of the main executives of the company.
- Significant locations and Subsidiaries - An inventory and contact details of main centers of operation and key partners (subsidiaries of the company).
- Main competitors - A list of the main competitors of the company.
- Main new developments - A succinct on latest news about the company.
Access comprehensive data on the company's financial transactions, company's expansion and divestiture and fund requirements
- The industry profile allows you to examine the company's financial transactions by region, by year, by industry segments and by category, for a five year period.
Gain knowledge on the growth and disinvestment strategy of the company
- The industry profile unveils transactions from the firm's core business segments' perspective to benefit you comprehend its business strategy.
Understand the main deals of the company with an overview of the recent financial transactions
- In-depth information on main recent deals includes a short statement of each deal, business deal type, deal motivation, financial deals and Target company's main financial metrics and ratios.
Get access to comprehensive data about the company's operations and detect potential clients and suppliers.
- The industry profile examines the corporate's business structure, areas and subsidiaries, main executives and key players.
Stay updated on main improvements affecting the firm
- Recent evolutions about the company exhibited in the profile advice you track main events.
Gain key aspects into the company for academic purposes or business purposes
- Highlight elements such as break up of transactions into types and info on detailed main deals are included into the industry profile to help your academic or business needs.
Note*: Some parts may be removed if info is not available for the company.This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.
Get Industry Insights. Simply.
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.
Category Manager at
Ikea
ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.
Executive Director at
PwC Advisory
The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!
Scott Griffith
Vice President Marketing at
Maurice Sporting Goods
The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research
Jessica P Huffman
Research Associate at
American Transportation Research Institute
Excellent customer service. Very responsive and fast.
Director, Corporate Strategy at
Ingredion
I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.
Mariana Mendoza
Global Platform Senior Manager at
Whirlpool Corporation
Thanks! I like what you've provided and will certainly come back if I need to do further research works.
Bee Hin Png
CEO at
LDR Pte Ltd
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.
Primary Biliary Cirrhosis - Pipeline Review, H2 2018
Primary Biliary Cirrhosis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Primary Biliary Cirrhosis - Pipeline Review, H2 2018, provides ...
Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H2 2018
Reflux Esophagitis (Gastro esophageal Reflux Disease) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis - Pipeline ...
Systemic Sclerosis (Scleroderma) - Pipelin ... $ 2000 July 2018
Mumps - Pipeline Review, H2 2018 $ 2000 July 2018
Non Alcoholic Fatty Liver Disease (NAFLD) ... $ 2000 July 2018
Warts - Pipeline Review, H2 2018 $ 2000 July 2018
Gastric Ulcers - Pipeline Review, H2 2018 $ 2000 September 2018
Tetanus - Pipeline Review, H2 2018 $ 2000 September 2018
Hand, Foot and Mouth Disease - Pipeline Re ... $ 2000 September 2018
NicOx S.A. - Quarterly Report, October 2018
Ophthalmology
Eye Disease
United States
France
North America
Balchem Corporation - Analyst Report, October 2018
Healthcare
Nutrition
World
Healthcare Industry - Company Report, October 2018
Dermatological ...
Clinical Trial
Asthma
ref:plp2018
Reportlinker.com © Copyright 2018. All rights reserved.